Human conglutinin-like protein inhibits infection by the human immunodeficiency virus-1 in vitro.
暂无分享,去创建一个
[1] L. Brigido,et al. Human immunodeficiency virus: novel enzyme-linked immunoassays for quantitation of envelope glycoprotein 120. , 1991, Journal of virological methods.
[2] E. Fenouillet,et al. Conglutinin Binds The HIV‐1 Envelope Glycoprotein gpl60 and Inhibits its Interaction with Cell Membrane CD4 , 1991, Scandinavian journal of immunology.
[3] H. Ushijima,et al. Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro. , 1991, Journal of acquired immune deficiency syndromes.
[4] D. Stewart,et al. Sulphoevernan, a polyanionic polysaccharide, and the narcissus lectin potently inhibit human immunodeficiency virus infection by binding to viral envelope protein. , 1990, The Journal of general virology.
[5] S. Thiel,et al. Characterization of a Lectin in Human Plasma Analogous to Bovine Conglutinin , 1987, Scandinavian journal of immunology.
[6] S. Thiel,et al. Demonstration in Human Plasma of a Lectin Activity Analogous to that of Bovine Conglutinin , 1987, Scandinavian journal of immunology.
[7] W. Müller,et al. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone. , 1987, Journal of the National Cancer Institute.